他汀类药物抗高血压作用的研究进展

被引:20
作者
董旭 [1 ]
刘素云 [2 ]
机构
[1] 河北医科大学中医院急诊科
[2] 河北医科大学第二医院心内科
关键词
高血压; 他汀类药物; 降压作用;
D O I
暂无
中图分类号
R544.1 [高血压]; R96 [药理学];
学科分类号
1002 ; 100201 ; 100602 ; 100706 ;
摘要
引用
收藏
页码:604 / 606
页数:3
相关论文
共 11 条
[1]   大剂量阿托伐他汀对高血压病患者血管活性物质水平的影响 [J].
王伟华 ;
陈月云 ;
薛成 ;
章辉 ;
徐浩 ;
纪勤炯 .
高血压杂志, 2005, (12) :762-766
[2]   氟伐他汀和辛伐他汀调脂外作用观察 [J].
鲁跃华 ;
陈爱武 ;
周传堃 ;
李珂 ;
葛正庆 ;
陈琴 ;
霍垚 ;
杨建南 ;
钱少平 .
四川大学学报(医学版), 2003, (03) :597-599
[3]  
Do Statins Reduce Blood Pressure?: A Meta-Analysis of Randomized, Controlled Trials[J] . Pasquale Strazzullo,Sally M. Kerry,Antonio Barbato,Marco Versiero Lanfranco D’Elia,Francesco P. Cappuccio.Hypertension . 2007 (4)
[4]  
Attenuation of homocysteine serum levels after short-term administration of simvastatin in essential hypertensives: Another pathway to cardiovascular risk reduction?[J] . Joanna Spiliopoulou,Efstathios Manios,George Tsivgoulis,Konstantinos Spengos,Konstantinos Dolianitis,Eleni Koroboki,George Rammos,Konstantinos Vemmos,Nikolaos Zakopoulos,Miron Mavrikakis.American Journal of Hypertension . 2005 (5)
[5]   Greater attenuation of blood pressure levels in salt sensitive hypertensive patients after short-term administration of simvastatin [J].
Spiliopoulou, J ;
Manios, E ;
Rammos, G ;
Tsivgoulis, G ;
Spengos, K ;
Dolianitis, K ;
Koroboki, E ;
Vemmos, K ;
Zakopoulos, N ;
Mavrikakis, M .
AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) :260A-260A
[6]   Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models [J].
Susic, D ;
Varagic, J ;
Ahn, J ;
Slama, M ;
Frohlich, ED .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (06) :1091-1097
[7]  
Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice[J] . Brain Research . 2002 (1)
[8]   Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death [J].
Knapp, AC ;
Huang, JW ;
Starling, G ;
Kiener, PA .
ATHEROSCLEROSIS, 2000, 152 (01) :217-227
[9]   Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia [J].
Borghi, C ;
Prandin, MG ;
Costa, FV ;
Bacchelli, S ;
Degli Esposti, D ;
Ambrosioni, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (04) :549-555
[10]   Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril) [J].
Spósito, AC ;
Mansur, AP ;
Coelho, OR ;
Nicolau, JC ;
Ramires, JAF .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (10) :1497-+